Literature DB >> 12848283

Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure.

Birthe Moesgaard1, Henrik H Hansen, Suzanne L Hansen, Steen Honore Hansen, Gitte Petersen, Harald S Hansen.   

Abstract

The N-acylethanolamine phospholipids (NAPE) are precursors for N-acylethanolamines (NAE), including anandamide (20:4-NAE), which is a ligand for the cannabinoid receptors. Previously, NAPE were believed to be found only in injured tissue, e.g., after neurodegenerative insults. Neuronal injury may occur in response to seizure activity. Therefore, we investigated the effect of pentylenetetrazol (PTZ)-induced seizures in PTZ-kindled mice on the level of NAPE in the brain. Male NMRI mice were kindled with PTZ injections 3 times/wk, thereby developing clonic seizures in response to PTZ. Mice were killed within 30 min after the clonic seizure on the test day (12th injection) and the brains were collected. Eight species of NAPE were analyzed as the glycerophospho-N-acylethanolamines by high-performance liquid chromatography-coupled electrospray ionization mass spectrometry. No effect of the PTZ kindling on the NAPE levels in murine brains was observed. Total NAPE in control mice cortex (n = 4) was 16.4 +/- 3.0 micromol/g wet weight of which 20:4-NAPE accounted for 3.6 mol%, and the major species was 16:0-NAPE, accounting for 52.1 mol%. Determination of the activity of NAPE-hydrolyzing phospholipase D and of N-acyltransferase in brain membrane preparations from adult and 3-d-old mice revealed an enzyme pattern in the adult mice that was favorable for NAE accumulation as opposed to NAPE accumulation. Thus, there was no difference in NAPE levels; at present, however, this does not exclude that NAE may accumulate during seizure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12848283     DOI: 10.1007/s11745-003-1073-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  27 in total

1.  The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat.

Authors:  D F Louw; F W Yang; G R Sutherland
Journal:  Brain Res       Date:  2000-02-28       Impact factor: 3.252

Review 2.  Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity.

Authors:  H S Hansen; L Lauritzen; B Moesgaard; A M Strand; H H Hansen
Journal:  Biochem Pharmacol       Date:  1998-03-15       Impact factor: 5.858

3.  Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration.

Authors:  H H Hansen; P C Schmid; P Bittigau; I Lastres-Becker; F Berrendero; J Manzanares; C Ikonomidou; H H Schmid; J J Fernández-Ruiz; H S Hansen
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

4.  Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death.

Authors:  H H Hansen; C Ikonomidou; P Bittigau; S H Hansen; H S Hansen
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

5.  Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons.

Authors:  H H Hansen; S H Hansen; A Schousboe; H S Hansen
Journal:  J Neurochem       Date:  2000-08       Impact factor: 5.372

6.  Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity.

Authors:  M van der Stelt; W B Veldhuis; P R Bär; G A Veldink; J F Vliegenthart; K Nicolay
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

7.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.

Authors:  D M Lambert; S Vandevoorde; G Diependaele; S J Govaerts; A R Robert
Journal:  Epilepsia       Date:  2001-03       Impact factor: 5.864

9.  Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.

Authors:  Henrik H Hansen; Iñigo Azcoitia; Sebastián Pons; Julián Romero; Luis Miguel García-Segura; José Antonio Ramos; Harald S Hansen; Javier Fernández-Ruiz
Journal:  J Neurochem       Date:  2002-07       Impact factor: 5.372

10.  Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine.

Authors:  T Sugiura; S Kondo; A Sukagawa; T Tonegawa; S Nakane; A Yamashita; Y Ishima; K Waku
Journal:  Eur J Biochem       Date:  1996-08-15
View more
  1 in total

1.  Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat.

Authors:  Nima Naderi; Leila Ahmad-Molaei; Farzad Aziz Ahari; Fereshteh Motamedi
Journal:  Neurochem Res       Date:  2011-04-23       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.